Management of Cardiovascular Risk Factors With Pioglitazone Combination Therapies in Type 2 Diabetes: An Observational Cohort Study

Cardiovascular Diabetology - United Kingdom
doi 10.1186/1475-2840-10-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Type 2 Diabetes and Cardiovascular Risk Factors

Current Medical Research and Opinion
Medicine
2011English

Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities

Circulation
Cardiovascular MedicinePhysiologyCardiology
2019English

Cardiovascular Risk in Patients With Type 2 Diabetes

CMAJ
Medicine
2005English

Detecting Pioglitazone Use and Risk of Cardiovascular Events Using Electronic Health Record Data in a Large Cohort of Chinese Patients With Type 2 Diabetes

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Cardiovascular Risk Factors and Mitral Annular Calcification in Type 2 Diabetes

Atherosclerosis
Cardiovascular MedicineCardiology
2013English

Impact of Diabetes Duration and Cardiovascular Risk Factors on Mortality in Type 2 Diabetes: The Hoorn Study

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2002English

Ethnic Differences in Control of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Attending an Inner London Diabetes Clinic

Postgraduate Medical Journal
Medicine
2006English

Contribution of Non Traditional Cardiovascular Risk Factors to the Cardiovascular Disease in Patient With Type 2 Diabetes

Zagazig University Medical Journal
2020English

Cardiovascular Risk Factor Burden in U.S. People With Incident Type 2 Diabetes Receiving Antidiabetic and Cardioprotective Therapies

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy